newdrugapprovals.org
FDA approves treatment Inrebic (fedratinib) for patients with rare bone marrow disorder
FDA approves treatment Inrebic (fedratinib) for patients with rare bone marrow disorder Today, the U.S. Food and Drug Administration approved Inrebic (fedratinib) capsules to treat adult patients w…